Deutsche Bank
RVMD icon

Deutsche Bank’s Revolution Medicines RVMD Stock Holding History

Deutsche Bank’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$235M Buy
1,144,679
+256,660
+29% +$50.9M 0.06% 268
2026
Q2 		$166M Buy
888,019
+422,261
+91% +$61.7M 0.05% 346
2026
Q1 		$45.3M Buy
465,758
+433,541
+1,346% +$43.8M 0.02% 648
2025
Q4 		$2.57M Buy
32,217
+130
+0.4% +$8.52K ﹤0.01% 1664
2025
Q3 		$1.5M Buy
32,087
+1,968
+7% +$77.1K ﹤0.01% 1941
2025
Q2 		$1.11M Sell
30,119
-123,227
-80% -$4.73M ﹤0.01% 2034
2025
Q1 		$5.42M Sell
153,346
-24,037
-14% -$976K ﹤0.01% 1218
2024
Q4 		$7.76M Buy
177,383
+64,997
+58% +$3.28M ﹤0.01% 1124
2024
Q3 		$5.1M Buy
112,386
+20,853
+23% +$908K ﹤0.01% 1274
2024
Q2 		$3.55M Sell
91,533
-5,328
-6% -$199K ﹤0.01% 1371
2024
Q1 		$3.12M Sell
96,861
-20,974
-18% -$622K ﹤0.01% 1458
2023
Q4 		$3.38M Buy
117,835
+64,834
+122% +$1.56M ﹤0.01% 1421
2023
Q3 		$1.47M Buy
53,001
+6,378
+14% +$189K ﹤0.01% 1506
2023
Q2 		$1.25M Sell
46,623
-59,654
-56% -$1.46M ﹤0.01% 1865
2023
Q1 		$2.3M Buy
106,277
+19,729
+23% +$486K ﹤0.01% 1607
2022
Q4 		$2.06M Buy
86,548
+4,076
+5% +$86.7K ﹤0.01% 1637
2022
Q3 		$1.63M Sell
82,472
-1,193
-1% -$26.2K ﹤0.01% 1713
2022
Q2 		$1.63M Sell
83,665
-2,843
-3% -$55.3K ﹤0.01% 1880
2022
Q1 		$2.21M Sell
86,508
-3,755
-4% -$81.7K ﹤0.01% 1824
2021
Q4 		$2.27M Buy
90,263
+907
+1% +$25.6K ﹤0.01% 1913
2021
Q3 		$2.46M Sell
89,356
-19,629
-18% -$571K ﹤0.01% 1939
2021
Q2 		$3.46M Buy
108,985
+29,273
+37% +$1.02M ﹤0.01% 1774
2021
Q1 		$3.66M Buy
79,712
+46,045
+137% +$2.06M ﹤0.01% 1745
2020
Q4 		$1.33M Buy
33,667
+12,666
+60% +$501K ﹤0.01% 2239
2020
Q3 		$731K Buy
21,001
+13,565
+182% +$376K ﹤0.01% 2401
2020
Q2 		$235K Buy
7,436
+2,531
+52% +$79.6K ﹤0.01% 3057
2020
Q1 		$107K Buy
+4,905
New +$136K ﹤0.01% 3218

Other funds holding RVMD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Mass General Brigham
Mass General Brigham Somerville, Massachusetts $456M AUM 27.51% 1-Year Est. Return

Deutsche Bank's RVMD Position: Q3 2026 in Review

Deutsche Bank increased its Revolution Medicines (RVMD) stake by 29% in Q3 2026, buying an estimated $50.9M and bringing the position to 1,144,679 shares worth $235M. The position accounts for 0.06% of the portfolio, ranked #268.

Deutsche Bank first reported a position in RVMD in Q1 2020 and has held it in 27 quarters since. 329 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Deutsche Bank held 1,144,679 shares of Revolution Medicines worth $235M as of Q3 2026.
  • Deutsche Bank bought 256,660 Revolution Medicines shares in Q3 2026, an estimated $50.9M.
  • Revolution Medicines made up 0.06% of Deutsche Bank's portfolio in Q3 2026, its #268 holding.
  • Deutsche Bank first reported a position in Revolution Medicines in Q1 2020 and has held it in 27 quarters since.
  • 329 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.